Bio-View Ltd (TLV:BIOV)
17.60
+0.90 (5.39%)
Jan 1, 2026, 1:31 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 23.45 million as of December 31, 2025. Its market cap has decreased by -27.31% in one year.
Market Cap
23.45M
Enterprise Value
17.47M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 23.45M, a decrease of -60.78%. That is a compound annual growth rate of -4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 23.45M | 4.79% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 114.15B |
| Danel (Adir Yeoshua) | 2.79B |
| Kamada | 1.30B |
| BrainsWay | 1.22B |
| Bait Bakfar | 1.01B |
| SofWave Medical | 981.37M |
| Ilex Medical | 745.80M |
| Novolog (Pharm-Up 1966) | 641.66M |